Good policy landing - drug cold chain logistics development to the good

?On February 7, the General Office of the State Council issued the Opinions on Further Strengthening the Work of Vaccination and Vaccination (hereinafter referred to as "Opinions"), which calls for strengthening the whole process of vaccine circulation. In this regard, the pharmaceutical supply chain unio Secretary-General Li Guowei that "opinions" is the last year after the implementation of the vaccine vaccine in Shandong Province, the implementation of two types of vaccine circulation of the New Deal sort out the clear distribution of pharmaceutical management requirements, to strengthen the vaccine management, promote drug cold chain logistics Is a major positive.

Put the risk of "double high"

Pharmaceutical cold chain transport with high input and high risk "double high" features. Suzhou point through the cold storage logistics Co., Ltd. Business Director Gao Hai Feng said that compared with the traditional logistics industry, pharmaceutical cold chain logistics industry profits, although about 20% to 30% higher, but the cold chain logistics costs and the risks are Much higher than traditional logistics. Its high input is mainly reflected in several aspects: hardware facilities, only a compliance refrigerated trucks, including chassis, cars, cold, the cost will be more than 500,000 yuan; enterprises need supporting the operation and management system, temperature control system Such as training, to encourage a number of specifically for the vehicle to verify the quality of service technology team, but also a small sum of money.

Beijing Hua Hin Logistics Co., Ltd. Deputy General Manager Chen Guangyan that the cold chain transport is the biggest risk is the temperature control problem, especially in the dynamic transport process. Because the cold chain products on the storage and transportation temperature requirements are very strict, once the product out of the appropriate temperature range, the temperature is too high or too low, are likely to have an impact on product quality. Such as vaccines, if not suitable for high temperature or low temperature storage, transport, it is possible to lose the immune effect, and even produce side effects. As some cold chain transport products are expensive, ranging from several hundred thousand dollars to tens of millions of dollars, once the problem, not only will cause great losses to the enterprise, but also to patients with security risks.

Storage and transportation to specifications

In recent years, with the gradual deepening of the pharmaceutical circulation system reform, medicine cold chain storage and transportation in the protection of drug quality and safety, reduce risk and so play an extremely important role. The new revised GSP on the cold storage and transportation of drugs put forward new requirements; the State Council in the "long-term development of the logistics industry (2014-2020)", specifically to discuss the long-term development of cold chain logistics; National Development and Reform Commission issued a " Market environment to promote the integration of traffic and transport development plan, "proposed, planning and construction of dangerous goods, cold chain and other specialized logistics facilities and equipment, establish and improve the whole process of dangerous goods regulatory system and emergency rescue system, improve the cold chain transport service standards, Keep the whole chain.
The release of these policies, the healthy development of the pharmaceutical cold chain logistics industry has played a very good role in promoting the cold chain logistics and pharmaceutical standardization and standardization.

The "opinions" to further strengthen the management of the distribution of the vaccine, requiring the National Health Commission, the State Food and Drug Administration in accordance with the "vaccine circulation and vaccination regulations," the relevant provisions of the timely revision and improvement of vaccine storage and transport management practices, Guide the establishment of a sound vaccine cold chain distribution management system to strengthen the cold chain storage and transportation process of standardized management. Provincial health care and food and drug regulatory authorities, to guide the vaccine manufacturers to choose a better cold chain storage and transportation conditions of the distribution business, to play a centralized distribution of efficiency advantages. Vaccine manufacturers can take the "trunk transport + regional storage + regional distribution" of the sub-relay delivery of the vaccine, trunk transport can be commissioned by professional cold chain transport enterprises, regional warehousing and regional distribution can be entrusted with cold chain storage and transportation conditions of the distribution business. The provinces (autonomous regions and municipalities) people's governments should take effective measures to ensure the timely delivery of vaccines in remote areas in combination with the actual situation in the region.

Market prospects

With the pharmaceutical cold chain logistics industry gradually standardized, cold chain distribution market has begun to be optimistic about the industry.
Chen Guangyan said that since last year's vaccine policy "one vote system" after the release of all the vaccine distribution into a direct distribution by the vaccine manufacturers to counties and cities. This is a certain difficulty for the vaccine manufacturers: First, resulting in longer delivery time, the situation may be insufficient vaccine supply; Second, when the number of vaccine transport, will increase the cost of business. "Vaccine manufacturers can transport links to the professional cold chain logistics enterprises to be responsible." Chen Guangyan said.

According to Li Guowei introduced at this stage, China's pharmaceutical cold chain distribution system can basically cover the second and third tier cities, but at the county level, there may be supply or other aspects of the problem. The introduction of the "opinions", clearly pointed out that the vaccine manufacturers can take "trunk transport + regional storage + regional distribution," the sub-relay delivery of the vaccine, not only the vaccine "one vote" policy supplement and improve, but also for medicine Cold chain distribution market development pointed out the direction.

In recent years, with the increase in demand for pharmaceutical products, pharmaceutical cold chain logistics industry began to rise. In 2016, the State Council issued the Decision on Canceling the Implementation of Administrative Examination and Approval Matters in 152 Central Designated Areas (Guo Fa [2016] No. 9) and canceled the approval of the third party pharmaceutical logistics business. This move means that the state liberalized the third party logistics enterprises to enter the field of medical logistics restrictions, a number of social logistics companies began to enter the pharmaceutical logistics industry. Such as Shun Feng Group in 2016 set up a "cold transport business unit", and with a number of pharmaceutical companies to reach cooperation, began to get involved in the field of medical cold chain distribution. It is reported that the future the company will also increase the cold chain of medicine and equipment investment, deep plowing cold transport industry.

With the implementation of the "opinions" and the entry of third-party logistics enterprises, it is believed that the cold chain distribution of medicine will be more standardized and the development prospect of cold chain transportation market will be more broad.